Wellbeing Digital Sciences Inc. — Board/Management Information 2020

Sep 19, 2020

MYCONIC CAPITAL CORP.

#340 – 1917 West 4[th] Avenue

Vancouver, BC V6J 1M7

NEWS RELEASE

September 18, 2020 – Vancouver, British Columbia, Canada – Myconic Capital Corp. (formerly, Auralite Investments Inc.) (TSXV:MEDI) (the " Company " or " Myconic ") is pleased to announce that Natasha Raey has been appointed as a Director of the Company effective immediately.

Natasha Raey is a serial entrepreneur and consultant whose current work is focused on the healthcare, cannabis, and wellness industries. Ms. Raey has managed the planning and development of large scale health centres in both Vancouver and Toronto. In 2017, she opened Cadence Health Centre, a team based multi-disciplinary health centre and pharmacy in downtown Toronto. In 2014, she co-founded SheTalks Global, an annual speaker series and conference showcasing influential women in diverse fields. Most recently, in 2019, Ms. Raey founded Bloom & Elix, an enterprise developing wellness and brain health supplements for women. She also serves as an independent business, marketing and public relations consultant for a number of social enterprises, public institutions and non-government organizations. Ms. Raey holds a Masters of Health Administration from The University of British Columbia, and BSc Molecular Biology and Biochemistry (Honors) from Simon Fraser University.

ABOUT MYCONIC

Myconic is an investment issuer with interests in, Canadian-based Champignon Brands Inc., educational technology developer Akiva Systems Inc., and Gold Lion Resources Inc.

On behalf of:

MYCONIC CAPITAL CORP.

" Robert Meister "

Robert Meister CEO and Director

For further information, please contact:

Robert Meister Tel: 604-351-6647 Or Email: rob@auraliteinvestments.com http://www.auraliteinvestments.com/

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

This news release contains forward-looking statements including statements regarding any of the Myconic holdings or investments, as well other statements that are not historical facts. Readers are cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are based will occur. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks and uncertainties, both general and specific, that

contribute to the possibility that the predictions, forecasts, projections and other forward-looking statements will not occur, which may cause actual performance and results in future periods to differ materially from any estimates or projections of future performance or results expressed or implied by such forward-looking statements. These assumptions, risks and uncertainties include, among other things, the state of the economy in general and capital markets in particular, investor interest in the business and future prospects of the Company.

The forward-looking statements contained in this news release are made as of the date of this news release. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable securities law. Additionally, the Company undertakes no obligation to comment on the expectations of, or statements made, by third parties in respect of the matters discussed above.